Last reviewed · How we verify
NCT05886309
Measurement of Serum Ferritin With a Cryo Detector Mass Spectrometer (CDMS)
trial testing Collection of Blood samples in Serum Ferritin in 22 participants. Completed in 5 May 2024.
5 March 2024
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 22 |
| Start date | 12 February 2024 |
| Primary completion | 5 March 2024 |
| Estimated completion | 5 May 2024 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Collection of Blood samples — full drug profile →
Conditions studied
- Serum Ferritin — all drugs for Serum Ferritin →
Sponsor
University Hospital, Basel, Switzerland
Who can join
Adults 18 to 75, any sex, with Serum Ferritin. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will explore the performance of the CDMS (Cryo Detector Mass Spectrometer) method in measuring SF (serum ferritin) in human serum of healthy individuals. This will be the first experience of testing SF with this method using biologic material of human origin.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05886309
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Collection of Blood samples
Trials testing the same drug.
- NCT03003845 — S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain · completed
Other recruiting trials for Serum Ferritin
Currently open trials in the same condition.
- NCT06702566 — The Effect of Serum Ferritin in irAE · NA · recruiting
- NCT06232642 — Effects of Lactoferrin-enriched Whey on Iron Status in Females · NA · active not recruiting
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05886309 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 15 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05886309.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing